BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2988226)

  • 1. Novel approaches to foot and mouth disease vaccination.
    Rowlands DJ
    Vaccine; 1985 Mar; 3(1):37-9. PubMed ID: 2988226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-response evaluation of a genetically engineered foot-and-mouth disease virus polypeptide immunogen in cattle.
    McKercher PD; Moore DM; Morgan DO; Robertson BH; Callis JJ; Kleid DG; Shire SJ; Yansura DG; Dowbenko D; Small B
    Am J Vet Res; 1985 Mar; 46(3):587-90. PubMed ID: 2986495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New approaches to vaccination against foot-and-mouth disease.
    Brown F
    Vaccine; 1992; 10(14):1022-6. PubMed ID: 1335197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effectiveness of foot-and-mouth disease vaccines in Switzerland. II. Stability problems].
    Ackermann M; Müller HK; Bruckner L; Kihm U
    Schweiz Arch Tierheilkd; 1989; 131(7):389-95. PubMed ID: 2552580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects for improved foot and mouth disease vaccines.
    Doel TR
    Vaccine; 1985 Mar; 3(1):35-6. PubMed ID: 2988225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic peptide vaccines against foot and mouth disease.
    Murdin AD
    Vaccine; 1986 Dec; 4(4):210-1. PubMed ID: 3026104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle.
    Sreenivasa BP; Mohapatra JK; Pauszek SJ; Koster M; Dhanya VC; Tamil Selvan RP; Hosamani M; Saravanan P; Basagoudanavar SH; de Los Santos T; Venkataramanan R; Rodriguez LL; Grubman MJ
    Vet Microbiol; 2017 May; 203():196-201. PubMed ID: 28619144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined vaccination of cattle against FMD and rabies.
    Palanisamy R; Ramanna BC; Ananda Rao K; Srinivasan VA
    Microbiologica; 1992 Jan; 15(1):45-9. PubMed ID: 1313530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against viral infections with the aid of synthetic peptides. Foot-and-mouth disease as an example.
    Vol'pina OM; Surovoi AYu ; Ivanov VT
    Biomed Sci; 1990 Jan; 1(1):23-32. PubMed ID: 1718462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Testing the effectiveness of foot-and-mouth disease vaccines: the relationship between test infection results and corresponding neutralization titers of vaccinated cattle].
    Bengelsdorff HJ
    Berl Munch Tierarztl Wochenschr; 1989 Jun; 102(6):193-8. PubMed ID: 2548473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of virus infection-associated antigen and 3D antibodies in cattle vaccinated against foot and mouth disease.
    O'Donnell VK; Smitsaart E; Cetra B; Duffy S; Finelli J; Boyle D; Draghi G; Fondevila N; Schudel AA
    Rev Sci Tech; 1997 Dec; 16(3):833-40. PubMed ID: 9567309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antigenic structure of the foot-and-mouth disease virus. II. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth disease virus type A22].
    Vol'pina OM; Surovoĭ AIu; Ul'iashin VV; Ivanov VT; Chepurkin AV
    Bioorg Khim; 1988 Oct; 14(10):1363-71. PubMed ID: 2852938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants.
    Taboga O; Tami C; Carrillo E; Núñez JI; Rodríguez A; Saíz JC; Blanco E; Valero ML; Roig X; Camarero JA; Andreu D; Mateu MG; Giralt E; Domingo E; Sobrino F; Palma EL
    J Virol; 1997 Apr; 71(4):2606-14. PubMed ID: 9060612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cattle response to foot-and-mouth disease virus nonstructural proteins as antigens within vaccines produced using different concentrations.
    Lubroth J; López A; Ramalho AK; Meyer RF; Brown F; Darsie GC
    Vet Q; 1998; 20 Suppl 2():S13-7. PubMed ID: 9652056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No significant differences in the breadth of the foot-and-mouth disease serotype A vaccine induced antibody responses in cattle, using different adjuvants, mixed antigens and different routes of administration.
    Tekleghiorghis T; Weerdmeester K; van Hemert-Kluitenberg F; Moormann RJ; Dekker A
    Vaccine; 2014 Sep; 32(41):5330-6. PubMed ID: 25092634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Seasonal variations in the formation of virus-neutralizing antibodies in cattle after vaccination against foot-and-mouth disease].
    Felfe P; Thalmann G; Kreienbrink G; Schiele K
    Arch Exp Veterinarmed; 1990; 44(2):199-204. PubMed ID: 2167046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic peptides as potential vaccines against foot-and-mouth disease.
    Brown F
    Endeavour; 1990; 14(2):87-94. PubMed ID: 1697533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an effective vaccine against foot-and-mouth disease with partially purified and concentrated virus antigen.
    Sen AK; Saha SN
    Acta Virol; 1994 Feb; 38(1):17-9. PubMed ID: 8067308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antigenic structure of the foot-and-mouth-disease virus. I. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth virus type O1K].
    Surovoĭ AIu; Vol'pina OM; Snetkova EV; Volkova TD; Ivanov VT
    Bioorg Khim; 1988 Oct; 14(10):1352-62. PubMed ID: 2852937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of foot-and-mouth disease virus replication in vaccinated cattle by antibodies to non-structural virus proteins.
    Berger HG; Straub OC; Ahl R; Tesar M; Marquardt O
    Vaccine; 1990 Jun; 8(3):213-6. PubMed ID: 2163574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.